Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Cholestyramine+aspartame 4g/sachet powder |
Is a |
Product containing colestyramine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bile acid sequestrant antilipemic agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Colestyramine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
Is a |
Aspartame-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caloric agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbohydrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aspartame |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
Is a |
Cholestyramine+aspartame |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Anion exchange resin |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
Has manufactured dose form |
Oral suspension (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Cholestyramine+aspartame 4g/sachet powder |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|